The researchers conducted a retrospective study to assess serum inflammatory biomarkers in patients with different subtypes ...

It is noteworthy that patients with mild TBI often report visual issues despite normal results of visual acuity measurements ...

Finnish researchers, Hanna Heloterä, Anna-Mari Viita, and Juha Laine, reported the results of a study in which they gained a better perspective on registry data and the changing workload in ...

EXG102 and EXG202 are investigational gene therapy candidates for wet age-related macular degeneration that are in ...

The phase 2b/3 trial of izokibep in non-infectious, non-anterior uveitis did not meet the primary endpoint of a statistically ...

Researchers described the presence of multiple bilateral serous retinal detachments (SRDs) found in 3 women after they used ...

A research team from Great Britain identified factors, such as mental health issues, lack of diabetic eye screening awareness, and transport difficulties, that interfere with attendance at annual ...

Panelists discuss how anti-VEGF therapies have dramatically improved visual outcomes in patients with age-related macular degeneration and diabetic macular edema over the past decade. Key challenges ...

Panelists discuss how aflibercept’s molecular structure contributes to its clinical efficacy as a standard treatment for retinal vascular diseases.

A recent study that compared 2 anti-vascular endothelial growth factor drugs for treating diabetic macular edema (DME) found that brolucizumab (Beovu, Novartis) was non-inferior in functional outcomes ...

XLRP is a severe, progressive inherited retinal disease that leads to blindness, typically by middle age, and currently has no approved treatments. It primarily affects young males, with an estimated ...